Semiquantitative assessment of sFRP4 expression confirmed that sFRP4 is robustly overexpressed in specimens of leiomyomas collected from the proliferative and luteal phase of the menstrual cycle (n = 20 each group; data not shown). The gene discussed is SFRP4; the disease is leiomyoma.